Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CWAN | Class A Common Stock | Options Exercise | $0 | +4.69K | +31.82% | $0.00 | 19.4K | Dec 31, 2024 | Direct | F1 |
transaction | CWAN | Class A Common Stock | Tax liability | -$65.4K | -2.38K | -12.24% | $27.52 | 17K | Dec 31, 2024 | Direct | F2 |
transaction | CWAN | Class A Common Stock | Options Exercise | $0 | +75K | +440.17% | $0.00 | 92K | Jan 1, 2025 | Direct | |
transaction | CWAN | Class A Common Stock | Tax liability | -$907K | -33K | -35.82% | $27.52 | 59.1K | Jan 1, 2025 | Direct | F2 |
transaction | CWAN | Class A Common Stock | Options Exercise | $0 | +9.38K | +15.87% | $0.00 | 68.4K | Jan 1, 2025 | Direct | |
transaction | CWAN | Class A Common Stock | Tax liability | -$131K | -4.76K | -6.96% | $27.52 | 63.7K | Jan 1, 2025 | Direct | F2 |
transaction | CWAN | Class A Common Stock | Options Exercise | $0 | +4.69K | +7.36% | $0.00 | 68.4K | Jan 1, 2025 | Direct | |
transaction | CWAN | Class A Common Stock | Tax liability | -$65.5K | -2.38K | -3.48% | $27.52 | 66K | Jan 1, 2025 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CWAN | Restricted Stock Unit | Options Exercise | $0 | -4.69K | -7.69% | $0.00 | 56.3K | Dec 31, 2024 | Class A Common Stock | 4.69K | $0.00 | Direct | F3, F4 |
transaction | CWAN | Restricted Stock Unit | Options Exercise | $0 | -75K | -33.33% | $0.00 | 150K | Jan 1, 2025 | Class A Common Stock | 75K | $0.00 | Direct | F5, F6 |
transaction | CWAN | Restricted Stock Unit | Options Exercise | $0 | -9.38K | -50% | $0.00 | 9.38K | Jan 1, 2025 | Class A Common Stock | 9.38K | $0.00 | Direct | F7, F8 |
transaction | CWAN | Restricted Stock Unit | Options Exercise | $0 | -4.69K | -50.01% | $0.00 | 4.69K | Jan 1, 2025 | Class A Common Stock | 4.69K | $0.00 | Direct | F7, F9 |
Id | Content |
---|---|
F1 | Reflects a correction to the previously reported amount of securities beneficially owned. As a result of a scrivener's error, a Form 4 was filed on March 1, 2024 that resulted in the number of securities beneficially owned by the Reporting Person to be understated by 1,563 shares. |
F2 | The disposition reported on this Form 4 represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The disposition is mandated by the Issuer and does not represent a discretionary transaction by the Reporting Person. |
F3 | 6.25% of the Restricted Stock Units shall vest at the end of each 3-month period for the next 4 years following January 1, 2024, and will settle within thirty days of the applicable vesting date. |
F4 | This represents the unvested portion of the RSUs granted on February 28, 2024 and does not include other RSUs with different grant dates or vesting terms. |
F5 | The Restricted Stock Units shall vest in 25% installments on each of the first four (4) anniversaries of the Vesting Period Commencement Date, provided that Participant does not incur a Termination prior to the applicable vesting date, beginning on 01-Jan-2023 |
F6 | This represents the unvested portion of the RSUs granted on February 20, 2023 and does not include other RSUs with different grant dates or vesting terms. |
F7 | The Restricted Stock Units shall vest in 25% installments on each of the first four (4) anniversaries of the Vesting Period Commencement Date, provided that Participant does not incur a Termination prior to the applicable vesting date, beginning on 01-Jan-2022 |
F8 | This represents the unvested portion of the RSUs granted on March 18, 2022 and does not include other RSUs with different grant dates or vesting terms. |
F9 | This represents the unvested portion of the RSUs granted on September 24, 2021 and does not include other RSUs with different grant dates or vesting terms. |